StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Employee tax withholding by Year

Employee tax withholding — Shares withheld on equity vesting (M shares) (M)

Vertex Pharmaceuticals Employee tax withholding: 0.70M in FY2025, down 22.2% from a year earlier.

Latest, FY2025
0.70
Period ended Dec 31, 2025
Change on a year earlier
-22.2%
0.90 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEmployee tax withholding — Shares withheld on equity vesting (M shares) (M)Year on yearSource
FY2025Dec 31, 20250.70-22.2%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20240.90+28.6%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20230.700.0%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 20220.70+16.7%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 20210.60-25.0%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 20200.80+2,566.7%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 20190.03–Form 10-K (filed 2021-02-11) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Employee tax withholding (M), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-tax-withhold-sh

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.